Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Vaney

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Revue Medicale Suisse|April 8, 2015
[Restore the connection...between physician and patient as well]Claude Vaney
Revue Medicale Suisse|April 8, 2015
[Cannabis in multiple sclerosis treatment: possibilities and limits]Claude Vaney
Revue Medicale Suisse|January 30, 2023
Claude Vaney, Barbara Broers
Revue Medicale Suisse|January 23, 2025
[Neurorehabilitation in Parkinson's disease : focus on physical therapy]André Zacharia, Quentin Lheureux, Claude Vaney
Expert Review of Clinical Pharmacology|June 9, 2022
Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?Carlos Vila Silván, Claude Vaney, Igor Dykukha
Revue Medicale Suisse|February 7, 2019
Claude Vaney, Laura Barin, Viktor Von Wyl
Multiple Sclerosis and Related Disorders|April 15, 2018
Recommended outcome measures for inpatient rehabilitation of multiple sclerosis are not appropriate for the patients with substantially impaired mobilityLaura Barin, Claude Vaney, Milo Alan Puhan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Long-term worsening of different body functions in persons with progressive multiple sclerosisMarco Kaufmann, Claude Vaney, Laura Barin, et al.
The American Journal of Psychiatry|October 3, 2009
Greater evidence of dissociative symptoms noted in general practitioners attending an educational session on dissociationCristian Damsa, Katharina Ruether, Eric Adam, et al.
Revue Medicale Suisse|January 20, 2023
[Integrative medicine: what's new in 2022]Caitriona Ungarelli-Mcevoy, Aurore Fernandez, Benedikt M Huber, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Revue Medicale Suisse|April 8, 2015
[Restore the connection...between physician and patient as well]Claude Vaney
Revue Medicale Suisse|April 8, 2015
[Cannabis in multiple sclerosis treatment: possibilities and limits]Claude Vaney
Revue Medicale Suisse|January 30, 2023
Claude Vaney, Barbara Broers
Revue Medicale Suisse|January 23, 2025
[Neurorehabilitation in Parkinson's disease : focus on physical therapy]André Zacharia, Quentin Lheureux, Claude Vaney
Expert Review of Clinical Pharmacology|June 9, 2022
Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?Carlos Vila Silván, Claude Vaney, Igor Dykukha
Revue Medicale Suisse|February 7, 2019
Claude Vaney, Laura Barin, Viktor Von Wyl
Multiple Sclerosis and Related Disorders|April 15, 2018
Recommended outcome measures for inpatient rehabilitation of multiple sclerosis are not appropriate for the patients with substantially impaired mobilityLaura Barin, Claude Vaney, Milo Alan Puhan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Long-term worsening of different body functions in persons with progressive multiple sclerosisMarco Kaufmann, Claude Vaney, Laura Barin, et al.
The American Journal of Psychiatry|October 3, 2009
Greater evidence of dissociative symptoms noted in general practitioners attending an educational session on dissociationCristian Damsa, Katharina Ruether, Eric Adam, et al.
Revue Medicale Suisse|January 20, 2023
[Integrative medicine: what's new in 2022]Caitriona Ungarelli-Mcevoy, Aurore Fernandez, Benedikt M Huber, et al.
Pageof 2